Kent Armeson
Overview
Explore the profile of Kent Armeson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
405
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lilly M, Wu C, Ke Y, Chen W, Soloff A, Armeson K, et al.
Clin Transl Med
. 2024 Mar;
14(3):e1627.
PMID: 38515274
Purpose: Our preclinical studies showed that lycopene enhanced the anti-prostate cancer efficacy of docetaxel in animal models. A phase I trial (NCT0149519) was conducted to identify an optimum dose of...
2.
Garand K, Armeson K, Hill E, Blair J, Pearson W, Martin-Harris B
Am J Speech Lang Pathol
. 2023 Oct;
33(1):460-467.
PMID: 37902448
Purpose: The purpose of this study was to test the feasibility for quantifying changes in oropharyngeal swallowing impairment in response to alteration in bolus viscosity using a reliable and valid...
3.
Sterba K, Armeson K, Zapka J, Garrett-Mayer E, Scallion M, Wall T, et al.
J Cancer Surviv
. 2022 Jun;
18(2):398-411.
PMID: 35761129
Purpose: Head and neck cancer (HNC) survivors and caregivers face significant challenges after treatment. This study's objective was to evaluate the effects of a dyadic survivorship care planning (SCP) intervention...
4.
Knochelmann H, Horton J, Liu S, Armeson K, Kaczmar J, Wyatt M, et al.
Cell Rep Med
. 2021 Nov;
2(10):100426.
PMID: 34755137
Oral cavity squamous cell carcinoma (OCSCC) is a prevalent surgically treated subset of head and neck cancer with frequent recurrence and poor survival. Immunotherapy has demonstrated efficacy in recurrent/metastatic head...
5.
Williams C, Phelps-Polirer K, Dingle I, Williams C, Rhett M, Eblen S, et al.
Oncogene
. 2021 May;
40(20):3635-3636.
PMID: 33958726
No abstract available.
6.
Garand K, Hill E, Armeson K, Martin-Harris B
Can J Speech Lang Pathol Audiol
. 2021 Mar;
44(1):1-8.
PMID: 33708276
The purpose of this study was to examine how aging and sex impacted scores on the Eating Assessment Tool-10 in a large sample of healthy, non-dysphagic adults. Differences in Eating...
7.
Development and implementation of the SUM breast cancer cell line functional genomics knowledge base
Ethier S, Guest S, Garrett-Mayer E, Armeson K, Wilson R, Duchinski K, et al.
NPJ Breast Cancer
. 2020 Jul;
6:30.
PMID: 32715085
Several years ago, the SUM panel of human breast cancer cell lines was developed, and these cell lines have been distributed to hundreds of labs worldwide. Our lab and others...
8.
Beall J, Hill E, Armeson K, Garand K, Davidson K, Martin-Harris B
Am J Speech Lang Pathol
. 2020 Jul;
29(2S):1001-1011.
PMID: 32650665
Purpose Our objectives were to (a) identify oral and pharyngeal physiologic swallowing impairment severity classes based on latent class analyses (LCAs) of the Modified Barium Swallow Impairment Profile (MBSImP) swallow...
9.
Knochelmann H, Dwyer C, Smith A, Bowers J, Wyatt M, Nelson M, et al.
Cancer Res
. 2020 Jun;
80(18):3920-3932.
PMID: 32561531
The accessibility of adoptive T-cell transfer therapies (ACT) is hindered by the cost and time required for product development. Here we describe a streamlined ACT protocol using Th17 cells expanded...
10.
Giordano A, Liu Y, Armeson K, Park Y, Ridinger M, Erlander M, et al.
PLoS One
. 2019 Nov;
14(11):e0224420.
PMID: 31751384
Within triple negative breast cancer, several molecular subtypes have been identified, underlying the heterogeneity of such an aggressive disease. The basal-like subtype is characterized by mutations in the TP53 gene,...